Gautam Patel, Director at Amneal Pharmaceuticals, Inc. (AMRX), sold 125,180 shares at $8.01 ($1.0M) on 2025-01-08, disclosed to the SEC on 2025-01-10.
Scheduled sale ($1.0M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.01 | 62,590 | $501K | 50.0% |
| 2 | $8.01 | 62,590 | $501K | 50.0% |
| Total | $8.01 avg | 125,180 | $1.0M | 100% |
| Filing → |
| AMRX | SELL | 2025-05-06 | $69K | — | Filing → |
| AMRX | SELL | 2025-04-02 | $664K | — | Filing → |
| AMRX | SELL | 2025-03-05 | $712K | — | Filing → |